NDC 23155-244-22 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23155-244
- Requested NDC
- 23155-244-22
- Package NDCs from labels
- 23155-244-22, 23155-244-45, 23155-244-46
- Manufacturer
- Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited
- Effective date
- 2019-10-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RIZATRIPTAN - Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited | Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited | 2019-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-244-22 | EA - Each | 23155-244 | 828359cf-ecc9-40d1-b5cd-c99059b64fa6 | 1 | 2019-07-02 |
| 23155-244-46 | EA - Each | 23155-244 | bafdbe0b-7f45-42aa-8756-b37c3f65c235 | 1 | 2014-10-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | DIRECT RX | 673d584c-0691-d2fb-e053-2991aa0a7797 | 2026-03-17 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Direct_Rx | f754388d-77f1-0d8d-e053-6394a90a7b7e | 2026-03-17 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate ODT | RIZATRIPTAN BENZOATE ODT | Direct_rx | 2c29e066-c018-22e7-e063-6294a90a035c | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | direct rx | b3d981bc-3c9e-8a9e-e053-2995a90a8f65 | 2026-03-05 | Warnings, Adverse reactions | WR978S7QHH |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Old East Main Co. | c38c77fd-abbf-4c87-a9c0-a0e21ed3f97d | 2026-03-02 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Chain Drug Marketing Association | 86ff4875-9007-4b7b-8f46-16cbd475d4bb | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Chain Drug Marketing Association | 6c848b98-f01c-40f2-a9aa-2af76cb370c8 | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Levico Prunus | LEVICO PRUNUS | Uriel Pharmacy Inc. | 63db9374-8ee2-48cf-8799-454c95869808 | 2026-02-27 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Family Dollar Stores, Inc | 1a03331e-3676-451c-be22-9a547e8ae6e2 | 2026-02-24 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Perrigo Direct, Inc | 256bd1d4-fd50-408f-9aee-84f218bb4971 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Perrigo Direct, Inc | 54a20ec9-ab86-4410-af94-e04393e9d4b3 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Meijer, Inc. | 6b369ef2-fd54-4931-a9eb-0fb42834c2ef | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Target Corporation | d4ee05c8-ae62-45df-8783-1ed57fa030ec | 2026-02-18 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Topco Associates LLC | 15d1ae3f-509c-4e6b-8f0c-cf9265680358 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Major Pharmaceuticals | c25be68d-834a-4959-8d47-01ec789406ba | 2026-02-04 | Warnings, Adverse reactions | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 11a7f243-3a8b-41fd-a9fa-1dd2dcafab93 | 2026-02-04 | Warnings, Adverse reactions | WR978S7QHH |
| Aquavit 1 | AQUAVIT 1 | Uriel Pharmacy Inc. | 2354fcfc-05a2-444a-ace4-b3df61413157 | 2026-02-02 | Warnings | 1K09F3G675 |
| MAXALT | RIZATRIPTAN BENZOATE | Organon LLC | 007b4644-e0e7-4863-9ae3-fe09676b3f5f | 2026-01-29 | Warnings, Adverse reactions | WR978S7QHH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.